PHASE 1 TRIAL OF THE LSD1 INHIBITOR SP-2577 (SECLIDEMSTAT) IN PATIENTS WITH RELAPSED OR REFRACTORY EWING SARCOMA AND SELECT SARCOMAS

Disease:

Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma, Soft Tissue, Desmoplastic Small Round Cell Tumor, Extraskeletal Myxoid Chondrosarcoma, Angiomatoid Fibrous Histiocytoma, Clear Cell Sarcoma, Primary Pulmonary Myxoid Sarcoma, Myoepithelial Tumor, Sclerosing Epithelioid Fibrosarcoma, Fibromyxoid Tumor

Study phase:

Phase I

Physician name:

Douglas Harrison

Department:

Pediatrics

For general questions about clinical trials:

1-877-632-6789